Michael B. Hoffman, Director, 10% Owner at Onconova Therapeutics, Inc. (ONTX), bought 143,480 shares at $8.03 ($1.2M) on 2014-02-20, disclosed to the SEC on 2014-02-24.
Scheduled purchase ($1.2M) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.03 | 71,740 | $576K | 47.4% |
| 2 | $8.91 | 71,740 | $639K | 52.6% |
| Total | $8.47 avg | 143,480 | $1.2M | 100% |
| Filing → |
| ANVS | BUY | 2025-12-08 | $194K | — | Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |